EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti‐TNF‐alpha—Results from a 12‐year multicentric observational prospective study

Alžběta Smetanová iD, Marek Pásek iD, Emanuel Marques iD, Jana Vránová, Petr Arenberger iD, Alena Machovcová, Zuzana Horáčková, Monika Arenbergerová iD, Biorep study group

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19916 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Alžběta Smetanová und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Third Faculty of Medicine, Charles University and Královské Vinohrady University Hospital, Prague, Czech R…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Hidradenitis Suppurativa, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHidradenitis SuppurativaTumor Necrosis Factor-alphaAdultFemaleHumansMaleMiddle AgedInfliximabProspective StudiesSkin Neoplasms

Substanzen

InfliximabTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Third Faculty of Medicine, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
  • Department of Pharmacology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Department of Medical Biophysics and Medical Informatics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Department of Dermatology and Venerology, University Hospital Motol, Prague, Czech Republic.

ORCID-Profile: Alžběta Smetanová, Marek Pásek, Emanuel Marques, Petr Arenberger, Monika Arenbergerová

Zitieren

APA

Smetanová, A., Pásek, M., Marques, E., Vránová, J., Arenberger, P., Machovcová, A., Horáčková, Z., Arenbergerová, M., & Biorep study group (2024). Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti‐TNF‐alpha—Results from a 12‐year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19916

Vancouver

Smetanová A, Pásek M, Marques E, Vránová J, Arenberger P, Machovcová A, et al. Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti‐TNF‐alpha—Results from a 12‐year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19916

BibTeX
@article{Smetanov2024,
  author = {Smetanová, Alžběta and Pásek, Marek and Marques, Emanuel and Vránová, Jana and Arenberger, Petr and Machovcová, Alena and Horáčková, Zuzana and Arenbergerová, Monika and Biorep study group, Biorep study group},
  title = {Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti‐TNF‐alpha—Results from a 12‐year multicentric observational prospective study},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19916}
}
Kostenlos starten →